Etiology and outcome of peritoneal dialysis in 100 patients with chronic renal failure in Al-Ramadi Teaching

Chronic renal failure is fatal disease because it leads to failure of excretory ,metabolic and endocrine functions of the kidneys which lead to disturb all physiological functions of the body some of these derangements is fatal to human beings to save human these body disturbances by chronic renal failure is treated by renal transplant and dialysis in different ways including peritoneal dialysis (PD.). Chronic renal failure is a common disease in patients attending Ramadi teaching hospital whom treated by peritoneal dialysis (PD) with variable results . So this study is introduced to detect the health status for managing chronic renal failure treated by peritoneal dialysis. All patients were 100 patients (53 male and 47 female) with CRF who admitted to the medical word in Al-Ramadi teaching hospital during a period from November 2008 till July 2009. Thorough history, examination and investigations were done for them including: hemoglobin, ESR ,blood urea, serum creatinine, ECG and abdominal U/S then PD was done for them according to their indications. The study showed that male was 53% with the age between 13 and 87 years while the female was 47% with the age between 12 and 91 years. Diabetes mellitus (DM) and hypertension (HT) were the most common cause of CRF. The outcome was: 30%complete improvement, 21% partial improvement, 26% less responsive and 23% died. In the last months of my study there was significant improvement. Inconclusion; DM and HT were the most common causes of CRF respectively; however obstructive uropathy had a notable ratio. There was no significant difference regarding sex. The outcome of PD was poor early in my study with significant improvements later.

Download Full-text

Abnormal Fibrin Stabilization in Renal Failure

Thrombosis and Haemostasis ◽

10.1055/s-0038-1651436 ◽

1969 ◽

Vol 22 (02) ◽

pp. 216-222 ◽

Cited By ~ 4

Author(s):

M. S Losowsky ◽

W. D Walls

Keyword(s):

Renal Failure ◽

Wound Healing ◽

Acute Renal Failure ◽

Peritoneal Dialysis ◽

Chronic Renal Failure ◽

Plasma Fibrinogen ◽

Contributory Factor ◽

Quantitative Technique ◽

Significant Difference

SummaryPlasma F.S.F. activity was measured by a quantitative technique in 41 patients with renal failure. It was subnormal in 35, being undemonstrable in 32.There was no significant difference in activity between patients with acute and patients with chronic renal failure, and co-existing jaundice had no significant effect on plasma F. S. F. activity.Plasma fibrinogen concentrations were frequently increased. Patients with the highest levels of plasma fibrinogen tended to retain demonstrable F.S.F. activity.Plasma F.S.F. activity was not related to the height of the blood urea.Haemodialysis and peritoneal dialysis had no significant effect on plasma F.S.F. activity.Plasma F.S.F. activity returned to normal following recovery of acute renal failure.Diminished plasma F.S.F. activity did not appear to be responsible for abnormal haemorrhage although it may act as a contributory factor.It is suggested that impaired fibrin stabilization might be responsible for abnormal wound healing in uraemia.

Download Full-text

PITUITARY HORMONES IN WOMEN WITH CHRONIC RENAL FAILURE: THE EFFECT OF CHRONIC INTERMITTENT HAEMO-AND PERITONEAL DIALYSIS

Acta Endocrinologica ◽

10.1530/acta.0.0800237 ◽

1975 ◽

Vol 80 (2) ◽

pp. 237-246 ◽

Cited By ~ 27

Author(s):

K. Ølgaard ◽

C. Hagen ◽

A. S. McNeilly

Keyword(s):

Growth Hormone ◽

Renal Failure ◽

Peritoneal Dialysis ◽

Chronic Renal Failure ◽

Significant Influence ◽

Follicle Stimulating Hormone ◽

Pituitary Hormones ◽

Plasma Prolactin ◽

Significant Difference ◽

Before And After

ABSTRACT Measurements of plasma prolactin (hPr), growth hormone (HGH), thyrotrophin (TSH), luteinizing (LH) – and follicle stimulating hormone (FSH) were performed in 20 women with chronic renal failure on regular dialysis. There was no significant difference in any of the hormone levels before and after the dialysis and no significant influence of the type of dialysis (haemodialysis and peritoneal dialysis) or the time of dialysis. Higher levels of plasma prolactin was found in the women on peritoneal dialysis than in the haemodialyzed women presumably due to the medical treatment. In the peritoneally dialyzed group four women had irregular menstruations and normal gonadotrophic levels, but elevated hPr and it is suggested that this finding is similar to that seen in the amenorrhoeagalactorrhoea syndrome, where hPr presumably in some way have anti-gonadotrophic actions at the gonadal level.

Download Full-text

Lercanidipin chylous peritonitis

Bulletin de la Dialyse à Domicile ◽

10.25796/bdd.v1i1.39 ◽

2018 ◽

Vol 1 (1) ◽

pp. 43-46

Author(s):

Hanene Gaied ◽

Maan Joseph

Keyword(s):

Renal Failure ◽

Peritoneal Dialysis ◽

Chronic Renal Failure ◽

Continuous Ambulatory Peritoneal Dialysis ◽

Rare Complication ◽

Drainage Fluid ◽

Common Causes

We report a case of lercanidipin-induced chylous peritonitis (CP) occurring in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD), a 22-year-old male with chronic renal failure with indeterminate nephropathy.. The patient presented a turbid drainage fluid at the start of peritoneal dialysis (PD). The chyloperitoneum resolved after stopping lercanidipin without recurrence.Lercanidipin induced-chyloperitoneum is a rare complication in PD. It is a benign form of non-infectious peritonitis that can be confused with an infectious peritonitis. The most common causes of CP are infectious, obstructive and abdominal malignancy.This paper discusses the possible causes of CP, the physiopathology and the management of lercanidipin-induced chyloperitoneum.

Download Full-text

Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm.2006.013 ◽

2006 ◽

Vol 44 (1) ◽

Cited By ~ 9

Author(s):

Elżbieta Kimak ◽

Andrzej Książek ◽

Janusz Solski

Keyword(s):

Renal Failure ◽

Peritoneal Dialysis ◽

Chronic Renal Failure ◽

Continuous Ambulatory Peritoneal Dialysis ◽

Healthy Subjects ◽

Linear Regression Analysis ◽

Multivariate Linear Regression Analysis ◽

Post Transplant ◽

Transplant Patients ◽

Lipoprotein Composition

AbstractStudies were carried out in 183 non-dialyzed, 123 hemodialysis, 81 continuous ambulatory peritoneal dialysis and 35 post-transplant patients and in 103 healthy subjects as a reference group. Lipids and apolipoprotein (apo)AI and apoB were determined using Roche kits. An anti-apoB antibody was used to separate apoB-containing apoCIII and apoE-triglyceride-rich lipoprotein (TRL) in the non-high-density lipoprotein (non-HDL) fraction from apoCIIInonB and apoEnonB in the HDL fraction in four groups of patients with chronic renal failure (CRF) and healthy subjects. Multivariate linear regression analysis was used to investigate the relationship between triglyceride (TG) or HDL-cholesterol (HDL-C) concentrations and lipoproteins. Dyslipidemia varied according to the degree of renal insufficiency, the type of dialysis and therapy regime in CRF patients. Lipoprotein disturbances were manifested by increased TG, non-HDL-C and TRL concentrations, and decreased HDL-C and apoAI concentrations, whereas post-renal transplant patients showed normalization of lipid and lipoprotein profiles, except for TG levels and total apoCIII and apoCIIInonB. The present study indicates that CRF patients have disturbed lipoprotein composition, and that hypertriglyceridemia and low HDL-C concentrations in these patients are multifactorial, being secondary to disturbed lipoproteins. The method using anti-apoB antibodies to separate apoB-containing lipoproteins in the non-HDL fraction from non-apoB-containing lipoproteins in HDL can be used in the diagnosis and treatment of patients with progression of renal failure or atherosclerosis. The variability of TG and HDL-C concentrations depends on the variability of TRL and cholesterol-rich lipoprotein concentrations, but the decreases in TG and increases in HDL-C concentrations are caused by apoAI concentration variability. These relationships, however, need to be confirmed in further studies.

Download Full-text

Expected ages in the patients of chronic diseases

Annals of King Edward Medical University ◽

10.21649/akemu.v10i4.1263 ◽

2016 ◽

Vol 10 (4) ◽

Author(s):

Intesaruk Rashid Khan ◽

Ahmed Imran Siddiqui ◽

Wafa Aftab

Keyword(s):

Heart Failure ◽

Renal Failure ◽

Retrospective Study ◽

Chronic Disease ◽

Chronic Renal Failure ◽

Hepatic Cirrhosis ◽

Disease Process ◽

Chronic Illnesses ◽

The Body ◽

Medical Wards

This retrospective study was conducted to find out the expected ages in the patients of hepatic cirrhosis, chronic renal failure and heart failure. This study thus covers most of the patients of out medical wards presenting with chronic illnesses. On comparison of these expected ages it is also found that the expected age in all these three groups is not much different. So, the disease process or the mechanism of the chronic disease in the body may be different, but somehow the final out come is not much different in terms of life span.

Download Full-text

Residual renal function and blood count in patients on continuous ambulatory peritoneal dialysis

Srpski arhiv za celokupno lekarstvo ◽

10.2298/sarh0612503j ◽

2006 ◽

Vol 134 (11-12) ◽

pp. 503-508

Author(s):

Natasa Jovanovic ◽

Mirjana Lausevic ◽

Biljana Stojimirovic

Keyword(s):

Renal Failure ◽

Renal Function ◽

Peritoneal Dialysis ◽

Chronic Renal Failure ◽

Continuous Ambulatory Peritoneal Dialysis ◽

Blood Count ◽

Residual Renal Function ◽

Co Morbidity ◽

Positive Correlations

Introduction:Most of patients with chronic renal failure are affected by normochromic, normocytic anemia caused by different etiological factors. Anemia causes a series of symptoms in chronic renal failure, which can hardly be recognized from the uremic signs. Anemia adds to morbidity and mortality rates in patients affected by advanced chronic renal failure. Blood count partially improves during the first months after starting the chronic renal replacement therapy, in correlation with the quality of depuration program, with extension of erythrocyte lifetime and with hemoconcentration due to reduction of plasma volume. Recent trials found that higher residual renal function (RRF) significantly reduced co-morbidity, the rate and duration of hospitalization and risk of treatment failure. Objective: The aim of the study was to follow blood count parameters in 32 patients on chronic continuous ambulatory peritoneal dialysis (CAPD) during the first six months of treatment, to evaluate the influence of demographic and clinical factors on blood count and RRF, and to examine the correlation between RRF and blood count parameters. Method: A total of 32 patients affected by end-stage renal disease of different major cause during the first six months of CADP treatment were studied. RRF and blood count were evaluated as well as their relationship during the follow-up. Results: Blood count significantly improved in our patients during the first six months of CAPD treatment even if Hb and HTC failed to reach normal values. Iron serum level slightly decreased because of more abundant erythropoiesis and iron utilization during the first six months of treatment. RRF slightly decreased. After six months of CAPD treatment, the patients with higher RRF had significantly higher Hb, HTC and erythrocyte number and a lot of positive correlations between RRF and anemia markers were observed. Conclusion: After 6-month follow-up period, the patients with higher RRF had significantly higher blood count parameters, and several positive correlations between RRF and blood count markers were confirmed.

Download Full-text